Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease
Autor: | Yamakawa, Hideaki, Sato, Shintaro, Ohta, Hiroki, Kusano, Kenji, Kawabe, Rie, Oba, Tomohiro, Uzuka, Chisa, Sasaki, Hiroki, Akasaka, Keiichi, Amano, Masako, Takemura, Tamiko, Araya, Jun, Matsushima, Hidekazu |
---|---|
Zdroj: | In Respiratory Investigation July 2024 62(4):551-557 |
Databáze: | ScienceDirect |
Externí odkaz: |